Skip to content

Value of liver reserve function test associated MELD scores in the assessment of prognosis of patients with hepatitis B-related acute-on-chronic liver failure.

Value of liver reserve function test associated MELD scores in the assessment of prognosis of patients with hepatitis B-related acute-on-chronic liver failure.

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039046
Enrollment
Unknown
Registered
2020-10-14
Start date
2020-11-01
Completion date
Unknown
Last updated
2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver failure

Interventions

Gold Standard:Clinical outcome
score&#32
for&#32
prediction

Sponsors

West China Hospital Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: The diagnostic criteria of ACLF were in accordance with the guidelines reported for the "Guideline for diagnosis and treatment of liver failure"(12) formulated in 2018. The clinical manifestations were as follows: (1) Extreme fatigue and obvious digestive tract symptoms; (2) Rapid jaundice deepening. Serum TBIL was 10 times higher than the upper limit of normal value or increased by >= 17.1µmol/L per day; (3) Bleeding tendency, PTA = 1.5), with the exception of patients with other causes; (4) Decompensated ascites; (5) Presence or absence of hepatic encephalopathy.

Exclusion criteria

Exclusion criteria: Patients with hepatitis A, hepatitis C, hepatitis D, hepatitis E, CMV, EBV infection, hyperthyroidism, autoimmune diseases, severe cardiopulmonary and renal insufficiency or malignant tumor, HIV infection, pregnancy, history of heavy drinking, recent history of antituberculosis drug use, recent history of Chinese herbal medicine, weight loss drugs, and various health care products.

Design outcomes

Primary

MeasureTime frame
3-month mortality;

Countries

China

Contacts

Public ContactMing Wang

Center of Infectious Diseases, West China Hospital Sichuan University

wangmingrbt@163.com+86 15882010821

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026